Evidence map›Paper›PMID 30986204›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2019

Avicularin Relieves Depressive-Like Behaviors Induced by Chronic Unpredictable Mild Stress in Mice.

Zhongfei Shen, Yun Xu, Xiaohong Jiang, Zhijian Wang, Yanjun Guo, Weiwei Pan, Jie Hou

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Retracted: Avicularin Relieves Depressive-Like Behaviors Induced by Chronic Unpredictable Mild Stress in Mice.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  3. Frontiers in pharmacology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Antidepressant Potential of Quercetin and itsFrontiers in pharmacology · 2022
    Review
  13. Article
  14. Article
  15. Molecules (Basel, Switzerland) · 2021
    Review
  16. Article
  17. Sex Differences in the Inflammatory Consequences of Stress: Implications for Pharmacotherapy.The Journal of pharmacology and experimental therapeutics · 2020
    Review
  18. Avicularin Reduces the Expression of Mediators of Inflammation and Oxidative Stress in Bradykinin-Treated MG-63 Human Osteoblastic Osteosarcoma Cells.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zhongfei ShenCollege of Medicine, Jiaxing University, Jiaxing, Zhejiang, China (mainland).
Yun XuCollege of Medicine, Jiaxing University, Jiaxing, Zhejiang, China (mainland).
Xiaohong JiangCollege of Medicine, Jiaxing University, Jiaxing, Zhejiang, China (mainland).
Zhijian WangCollege of Medicine, Jiaxing University, Jiaxing, Zhejiang, China (mainland).
Yanjun GuoCollege of Medicine, Jiaxing University, Jiaxing, Zhejiang, China (mainland).
Weiwei PanCollege of Medicine, Jiaxing University, Jiaxing, Zhejiang, China (mainland).
Jie HouCollege of Medicine, Jiaxing University, Jiaxing, Zhejiang, China (mainland).
Jiaxing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Avicularin (AL, quercetin-3-alpha-l-arabinofuranoside), a glycoside of quercetin, has been reported to display diverse pharmacological properties. The present study aimed to investigate whether AL has an anti-depressant-like effect on a mouse model of depression induced by chronic unpredictable mild stress (CUMS). MATERIAL AND METHODS A mouse model of depression was established and treated with different concentrations of AL (1.25, 2.5 or 5.0 mg/kg/d) and fluoxetine (20 mg/kg/d). Then, behavioral tests - sucrose preference test (SPT), forced swimming test (FST), and the tail suspension test (TST) - were performed. The levels proinflammatory cytokines - interleukin-1ß (IL-1ß), IL-6, and tumor necrosis factor-alpha (TNF-alpha) - in the hippocampi of mice were detected by enzyme-linked immunosorbent assay (ELISA). Apoptosis of hippocampal neuronal cells was determined using flow cytometry. Expression levels of phosphorylated (p)-MEK1/2, p-ERK1/2, p-NF-kappaB (p-p65), inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), Caspase3, and B-cell lymphoma 2 (Bcl-2)-associated X protein (Bax) were measured by Western blot assay or/and quantitative real-time polymerase chain reaction (qRT-PCR), respectively. RESULTS The results showed that AL significantly relieved CUMSinduced depressive-like behaviors. Compared with the model mice, AL treatment significantly increased the sucrose preference of the mice, and the immobility time in the FST and the TST were shortened. We also found that AL decreased CUMS-induced increases in the levels of IL-1ß, IL-6, and TNF-alpha in the hippocampi of mice. AL significantly decreased the apoptosis rate of hippocampal neuronal cells in mice, which was increased by CUMS. Furthermore, activation of the MEK/ERK/NF-kappaB pathway induced by CUMS was inhibited by AL treatment. CONCLUSIONS Our results show the anti-depressant-like effects of AL on CUMS-induced depression in a mouse model.

Indexed as

AnimalsAntidepressive AgentsBehavior, AnimalCytokinesDepressionDepressive DisorderDisease Models, AnimalFlavonoidsHippocampusInterleukin-1betaInterleukin-6MaleMiceMice, Inbred C57BLQuercetinStress, PsychologicalAntidepressive AgentsavicularinCytokinesFlavonoidsInterleukin-1betaInterleukin-6QuercetinTumor Necrosis Factor-alpha

Identifiers

PMID30986204
PMCPMC6482862
OpenAlexW2937161168

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.